JMP Securities Reiterates Market Perform Rating for Apyx Medical (NASDAQ:APYX)

JMP Securities reissued their market perform rating on shares of Apyx Medical (NASDAQ:APYX) in a research note published on Monday morning, Benzinga reports.

Apyx Medical Price Performance

Shares of NASDAQ:APYX opened at $1.09 on Monday. The company has a debt-to-equity ratio of 2.26, a quick ratio of 4.45 and a current ratio of 5.33. The firm has a market cap of $37.76 million, a price-to-earnings ratio of -1.65 and a beta of 1.20. The firm has a fifty day moving average price of $1.26 and a 200 day moving average price of $1.42. Apyx Medical has a fifty-two week low of $0.97 and a fifty-two week high of $3.90.

Apyx Medical (NASDAQ:APYX) last issued its quarterly earnings data on Thursday, August 8th. The company reported ($0.19) earnings per share for the quarter, missing analysts’ consensus estimates of ($0.18) by ($0.01). The firm had revenue of $12.15 million for the quarter, compared to analysts’ expectations of $12.67 million. Apyx Medical had a negative net margin of 57.86% and a negative return on equity of 105.45%. During the same quarter in the previous year, the business earned ($0.11) EPS. As a group, sell-side analysts expect that Apyx Medical will post -0.69 earnings per share for the current fiscal year.

Institutional Trading of Apyx Medical

Hedge funds and other institutional investors have recently bought and sold shares of the stock. AIGH Capital Management LLC boosted its stake in Apyx Medical by 7.7% during the fourth quarter. AIGH Capital Management LLC now owns 2,040,540 shares of the company’s stock worth $5,346,000 after buying an additional 145,309 shares during the period. Kingsview Wealth Management LLC grew its position in shares of Apyx Medical by 156.7% in the 1st quarter. Kingsview Wealth Management LLC now owns 31,028 shares of the company’s stock worth $42,000 after buying an additional 18,943 shares during the last quarter. ProVise Management Group LLC acquired a new position in shares of Apyx Medical during the fourth quarter worth $35,000. Commonwealth Equity Services LLC purchased a new stake in shares of Apyx Medical during the 1st quarter valued at $676,000. Finally, Worth Venture Partners LLC boosted its position in shares of Apyx Medical by 12.0% in the 4th quarter. Worth Venture Partners LLC now owns 518,198 shares of the company’s stock worth $1,358,000 after purchasing an additional 55,592 shares in the last quarter. Hedge funds and other institutional investors own 55.33% of the company’s stock.

About Apyx Medical

Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures.